GPT and metabolic dysfunction-associated steatotic liver disease: The aim of this study was to compare and validate the diagnostic accuracy and clinical utility of noninvasive tests, including AST/ALT ratio, APRI, BARD score, FIB‐4 score, and NFS, in a cohort of biopsy‐proven NAFLD patients.